CardioLogical Solutions announced that it has been issued two additional patents for its family of aortic embolic protection devices designed to prevent stroke and other ischemic complications. The new patents include its first issued patent for its Emboline CAP technology, the only aortic embolic protection solution to offer comprehensive arterial protection, as well as a further patent for its broad embolic deflector intellectual property portfolio. CardioLogical Solutions now has four issued patents for aortic embolic protection.

Helium, MRI

The U.S. Senate passed legislation Sept. 26 to reauthorize, extend and improve operations of the Federal Helium Reserve in Texas, which will guarantee a stable supply of the gas used for cooling magnetic resonance imaging (MRI) systems.

 
Ultraspect dose lowering software for nuclear imaging, SPECT imaging, reconstructions.
GE Brivo NM615 SPECT system can help lower SPECT nuclear imaging dose.

The highest levels of radiation dose in medical imaging are reported in nuclear medicine and pressure is growing for lower dose.
CTA, CCTA, CT angiography

A large number of emergency room visits are for chest pain evaluation, and many hospitals are adopting CT angiography as a primary test to quickly rule-out coronary disease.

When leaders at Methodist Le Bonheur Healthcare (MLH), a not-for-profit health system based in Memphis, Tenn., saw the opportunity to standardize their suite of diagnostic imaging solutions, they capitalized on it. The seven-hospital system will deploy McKesson’s portfolio of enterprise medical imaging products across its various facilities to help improve physician collaboration, streamline data management and simplify its imaging archive process with a single point of access.

 
 

Patient enrollment has been initiated in a post-market registry for the COMBO Dual Therapy Stent to evaluate its long-term safety and performance in routine clinical practice. The prospective, multicenter, all-comers REMEDEE Registry (Multicenter, Prospective, Clinical Outcomes After Deployment of the Abluminal Sirolimus Coated Bio-Engineered Stent (Combo Bio-Engineered Sirolimus Eluting Stent) Post Market Registry) will enroll 1,000 patients at nine European sites. More than 100 patients have already been enrolled.

JenaValve Technology, Inc. announced that it has raised $62.5 million in a Series C venture round.

Rox Medical has crossed the halfway point in the CONTROL-HTN international, multi-center, randomized controlled hypertension trial. The milestone was met with the enrollment of the first patient from Prof. Markus van der Giet and Prof. Walter Zidek of the Charite Hospital, Benjamin Franklin Campus, Berlin. The CONTROL-HTN trial is evaluating the Rox Flow procedure — creating a small connection between artery and vein in the upper leg - for the treatment of resistant hypertension.

Parker Laboratories is introducing three, completely redesigned Thermasonic Gel Warmers at RSNA 2013. These include a single bottle gel warmer, a three-bottle gel warmer with preset temperature options and LED indicators, and a three-bottle gel warmer with LCD readout and temperature adjustment in one degree increments, in either Fahrenheit or Celsius.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now